RE: Missed Opportunities11 Oct 2022 13:48
If Ranger works well in the oncology sector, (Labcorp seem to think so) then I think that is where it will do especially well imo. Of course Nipt should also do well with Ambry/EKF etc, not to mention infectious disease/ vaccine companies.